Ancylostomiasis medical therapy: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(14 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Ancylostomiasis}}
{{Ancylostomiasis}}
{{CMG}}
{{CMG}} {{AE}} {{Kalpana Giri}}


==Overview==
==Overview==
[[Anti-helminthic]] [[therapies]] are recommended among [[patients]] with [[ancylostomiasis]]. [[Efficacy]] of [[treatment]] varies according to the [[severity]] of [[infection]], [[geographical]] [[distribution]], and [[age groups]]. [[Multiple blood transfusion]], [[iron supplements]] are also be given in severe cases.


==Medical Therapy==
==Medical Therapy==


[[Anti-helminthic]] [[therapies]] are recommended among [[patients]] with [[ancylostomiasis]].<ref name="pmid27929101">{{cite journal| author=Loukas A, Hotez PJ, Diemert D, Yazdanbakhsh M, McCarthy JS, Correa-Oliveira R | display-authors=etal| title=Hookworm infection. | journal=Nat Rev Dis Primers | year= 2016 | volume= 2 | issue=  | pages= 16088 | pmid=27929101 | doi=10.1038/nrdp.2016.88 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27929101  }} </ref>
[[Anti-helminthic]] [[therapies]] are recommended among [[patients]] with [[ancylostomiasis]]. [[Efficacy]] of [[treatment]] varies according to the [[severity]] of [[infection]], [[geographical]] [[distribution]], and [[age groups]].<ref name="pmid27929101">{{cite journal| author=Loukas A, Hotez PJ, Diemert D, Yazdanbakhsh M, McCarthy JS, Correa-Oliveira R | display-authors=etal| title=Hookworm infection. | journal=Nat Rev Dis Primers | year= 2016 | volume= 2 | issue=  | pages= 16088 | pmid=27929101 | doi=10.1038/nrdp.2016.88 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27929101  }} </ref>
*'''Adult'''
**'''For stable uncomplicated cases'''
***Preferred regimen: [[albendazole]] 400 mg PO single dose. If failed to respond it is recommended to administer albendazole 400 mg PO q24 h for 3 days or 800 mg PO as a single dose<ref name="pmid31622567">{{cite journal| author=Ronquillo AC, Puelles LB, Espinoza LP, Sánchez VA, Luis Pinto Valdivia J| title=Ancylostoma duodenale as a cause of upper gastrointestinal bleeding: a case report. | journal=Braz J Infect Dis | year= 2019 | volume= 23 | issue= 6 | pages= 471-473 | pmid=31622567 | doi=10.1016/j.bjid.2019.09.002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31622567  }} </ref>
***Alternative regimen: [[mebendazole]] 100 mg PO q12h for 3 days.<ref name="pmid27929101">{{cite journal| author=Loukas A, Hotez PJ, Diemert D, Yazdanbakhsh M, McCarthy JS, Correa-Oliveira R | display-authors=etal| title=Hookworm infection. | journal=Nat Rev Dis Primers | year= 2016 | volume= 2 | issue=  | pages= 16088 | pmid=27929101 | doi=10.1038/nrdp.2016.88 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27929101  }} </ref>
***Alternative regimen: [[pyrantel pamoate]] 11mg/kg PO q24h for 3 days (maximum, 1gm per dose)
**'''For unstable complicated cases'''
***[[Albendazole]] 400 mg PO q24 h for 3 days<ref name="pmid31622567">{{cite journal| author=Ronquillo AC, Puelles LB, Espinoza LP, Sánchez VA, Luis Pinto Valdivia J| title=Ancylostoma duodenale as a cause of upper gastrointestinal bleeding: a case report. | journal=Braz J Infect Dis | year= 2019 | volume= 23 | issue= 6 | pages= 471-473 | pmid=31622567 | doi=10.1016/j.bjid.2019.09.002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31622567  }} </ref>
***[[Mebendazole]] 100 mg PO q24 h for 5 days
***Multiple  blood transfusion
***Iron supplements


*'''For stable uncomplicated cases'''
*'''Pediatric'''
**'''Adult'''
**'''Children <2 years of age'''
***Preferred regimen: Albendazole 400 mg PO single dose
***Currently, for the [[treatment]] of young [[infants]], no guidelines are [[available]]. But current [[knowledge]] shows that the [[side effects]] linked to [[benzimidazole]] drugs in young children are likely to be the same as in older [[children]] and [[adults]]. Therefore, for the [[potential]] [[benefit]] of [[physical]] and [[cognitive development]], the [[treatment]] of [[young infants]] could be [[justified]].<ref name="pmid12745139">{{cite journal| author=Montresor A, Awasthi S, Crompton DW| title=Use of benzimidazoles in children younger than 24 months for the treatment of soil-transmitted helminthiasis. | journal=Acta Trop | year= 2003 | volume= 86 | issue= 2-3 | pages= 223-32 | pmid=12745139 | doi=10.1016/s0001-706x(03)00042-1 | pmc=5633076 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12745139  }} </ref>
***Alternative regimen: Mebendazole 100 mg PO q12h for 3 days
***Preferred regimen: [[albendazole]] 200 mg PO single dose.<ref name="pmid20228435">{{cite journal| author=Bhatia V, Das MK, Kumar P, Arora NK| title=Infantile hookworm disease. | journal=Indian Pediatr | year= 2010 | volume= 47 | issue= 2 | pages= 190-2 | pmid=20228435 | doi=10.1007/s13312-010-0033-2 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20228435  }} </ref>
***Alternative regimen: Pyrantel Pamoate 11mg/kg PO q24h for 3 days (maximum, 1gm per dose)
***Alternative regimen: [[mebendazole]] 100 mg PO q12h for 3 days.<ref name="pmid33563313">{{cite journal| author=Umbrello G, Pinzani R, Bandera A, Formenti F, Zavarise G, Arghittu M | display-authors=etal| title=Hookworm infection in infants: a case report and review of literature. | journal=Ital J Pediatr | year= 2021 | volume= 47 | issue= 1 | pages= 26 | pmid=33563313 | doi=10.1186/s13052-021-00981-1 | pmc=7871578 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33563313  }} </ref>


==References==
==References==

Latest revision as of 21:29, 3 December 2021

Ancylostomiasis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Ancylostomiasis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

Endoscopy

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Ancylostomiasis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Ancylostomiasis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Ancylostomiasis medical therapy

CDC on Ancylostomiasis medical therapy

Ancylostomiasis medical therapy in the news

Blogs on Ancylostomiasis medical therapy

Directions to Hospitals Treating Ancylostomiasis

Risk calculators and risk factors for Ancylostomiasis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalpana Giri, MBBS[2]

Overview

Anti-helminthic therapies are recommended among patients with ancylostomiasis. Efficacy of treatment varies according to the severity of infection, geographical distribution, and age groups. Multiple blood transfusion, iron supplements are also be given in severe cases.

Medical Therapy

Anti-helminthic therapies are recommended among patients with ancylostomiasis. Efficacy of treatment varies according to the severity of infection, geographical distribution, and age groups.[1]

  • Adult
    • For stable uncomplicated cases
      • Preferred regimen: albendazole 400 mg PO single dose. If failed to respond it is recommended to administer albendazole 400 mg PO q24 h for 3 days or 800 mg PO as a single dose[2]
      • Alternative regimen: mebendazole 100 mg PO q12h for 3 days.[1]
      • Alternative regimen: pyrantel pamoate 11mg/kg PO q24h for 3 days (maximum, 1gm per dose)
    • For unstable complicated cases

References

  1. ↑ 1.0 1.1 Loukas A, Hotez PJ, Diemert D, Yazdanbakhsh M, McCarthy JS, Correa-Oliveira R; et al. (2016). "Hookworm infection". Nat Rev Dis Primers. 2: 16088. doi:10.1038/nrdp.2016.88. PMID 27929101.
  2. ↑ 2.0 2.1 Ronquillo AC, Puelles LB, Espinoza LP, Sánchez VA, Luis Pinto Valdivia J (2019). "Ancylostoma duodenale as a cause of upper gastrointestinal bleeding: a case report". Braz J Infect Dis. 23 (6): 471–473. doi:10.1016/j.bjid.2019.09.002. PMID 31622567.
  3. ↑ Montresor A, Awasthi S, Crompton DW (2003). "Use of benzimidazoles in children younger than 24 months for the treatment of soil-transmitted helminthiasis". Acta Trop. 86 (2–3): 223–32. doi:10.1016/s0001-706x(03)00042-1. PMC 5633076. PMID 12745139.
  4. ↑ Bhatia V, Das MK, Kumar P, Arora NK (2010). "Infantile hookworm disease". Indian Pediatr. 47 (2): 190–2. doi:10.1007/s13312-010-0033-2. PMID 20228435.
  5. ↑ Umbrello G, Pinzani R, Bandera A, Formenti F, Zavarise G, Arghittu M; et al. (2021). "Hookworm infection in infants: a case report and review of literature". Ital J Pediatr. 47 (1): 26. doi:10.1186/s13052-021-00981-1. PMC 7871578 Check |pmc= value (help). PMID 33563313 Check |pmid= value (help).

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Ancylostomiasis_medical_therapy&oldid=1716891"